The use of the odds ratio product and self-reported data to detect comorbid insomnia and sleep apnea

Study Objectives To evaluate the utility of the odds ratio product (ORP) in differentiating comorbid insomnia and sleep apnea (COMISA) from obstructive sleep apnea (OSA) and chronic insomnia (CIN). Methods We retrospectively analyzed 9750 patients in four groups: (1) 1152 controls, (2) 2395 with CIN, (3) 2297 with OSA, and (4) 3906 with COMISA. CIN was defined as difficulty initiating/maintaining sleep with daytime fatigue/sleepiness occurring “often”/“always.” OSA was defined as an apnea-hypopnea index ≥5 on polysomnography. ORP, computed every 3 s from polysomnography, was analyzed alongside sleep metrics, comorbidities, and sleep habits. Associations were assessed using univariate multinomial logistic regression, followed by stepwise regression to identify independent predictors of COMISA versus OSA or CIN. Machine learning models classified COMISA, OSA, and CIN as distinct clinical groups. Results ORP-derived features showed stronger associations with COMISA than traditional sleep metrics (except N3 latency). Independent objective predictors of COMISA included male sex (OR=1.31, 95% CI=[1.16, 1.47]), BMI (1.27, [1.25, 1.29]), N3 latency (1.21, [1.13, 1.29]), age (1.17, [1.16, 1.19]), peak ORP during spontaneous arousals (1.12, [1.01, 1.25]), and time in ORP decile 7 (1.10, [1.07, 1.13]). Subjective predictors included depression, hypertension, allergy, headache, sleep aid/alcohol use, sleepiness, and lower sleep duration. Machine learning achieved overall accuracy of 61.2 per cent (p<.05), with sensitivity of 71 per cent for COMISA, 65 per cent for OSA, and 43 per cent for CIN. Conclusions ORP is a promising objective marker for COMISA, distinguishing it from OSA more effectively than sleep metrics but separating COMISA from CIN poorly.